University of California, Berkeley at CTAD 2026
Nov 16–19, 2026 Boston, MA ~1.7k attendees Website
University of California, Berkeley takes part in 2 sessions at CTAD 2026 in Boston. Its program centres on combining fluid biomarkers and PET imaging. Its work covers when plasma p-tau217 and amyloid PET disagree across ethnoracial groups and multimodal biomarkers for understanding disease and testing therapies.
| Organization | CTAD 2026 Attendance |
|---|---|
University of California, Berkeley Berkeley, California | |
Its Helen Wills Neuroscience Institute leads amyloid and tau PET research on brain ageing and Alzheimer's disease. | Talk Tue Nov 17 1:50pm |
Instantly find 20 buyers from University of California, Berkeley
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the CTAD Conference. Organization details are derived from CTAD’s published program, poster list and sponsor page. Submit a correction